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INVITED COMMENTARY
Peter L. Faries, MD, New York, NY
Chahwan and colleagues have provided a valuable analysis of
their single-center experience with abdominal aortic aneurysm
(AAA) repair. Their review analyzes the short-term and intermedi-
ate-term results of standard open repair and endovascular repair
(EVAR) performed using a wide variety of stent grafts and high-
lights several important areas that are of interest. Of particular
note, the authors are to be congratulated on obtaining excellent
results—particularly with open AAA repair—where they achieved a
mortality rate of 3.5% compared with 2.7% for EVAR (P  NS).
With this low perioperative mortality rate for open repair and
the relatively small sample size, the authors were able to negate any
significant perioperative survival advantage for EVAR. This mirrors
the results of the pivotal trials reported for the AneuRx1
(Medtronic, Minneapolis, Minn), Excluder,2 (W.L. Gore and As-
sociates, Flagstaff, Ariz) and Zenith3 (Cook, Bloomington, Ind)
devices. Only in studies that evaluated much larger patient popu-
lations could significantly lower perioperative mortality be demon-
strated for endovascular repair.4
The current study did demonstrate significant advantages with
respect to operative blood loss and hospital length of stay, again
similar to the previously reported pivotal trials. These findings rein-
force previously published analyses that indicate success in preventing
aneurysm-related death can be achieved in appropriately selected
patients using conventional open repair techniques. The increase in
perioperativemorbidity associated with open repair may ultimately be
balanced by its increased durability. This is suggested by the authors’
finding of increased survival at the 3-year time point. Although this
could not be related to increased aneurysm-related mortality in the
EVARgroup, and the overall survival curves did not vary significantly,
the finding is interesting. Whether it implies the patients who under-
went open repair receivedmore thoroughmanagement of cardiac and
other comorbid medical conditions or another more difficult-to-
define cause cannot be determined from the current study.
The distribution of open and endovascular repair procedures is
also interesting. In this population, considerably more patients
were treated with open repair (n  417) than with EVAR (n 
260). This appears to be in distinction tomost published series, but
may be a more accurate reflection of general practice during the
decade being studied. The authors do note a trend toward increas-
ing use of EVAR in their patient population. This has resulted in
longer follow-up for patients treated by standard open repair. It is
difficult to determine if this influenced the reported rates for
reintervention because these are not analyzed by the type of repair
performed.
Of concern in the analysis is the selection of the type of repair
procedure performed. Although the authors suggest that they
favored open repair for patients who were generally younger (on
average 71 vs 74 years old), the patients treated with open repair
did not appear to have an increased number of comorbid medical
conditions. Whether this reflects a limitation of the analysis of
comorbid factors that limits the ability to distinguish the extent of
the comorbid disease or whether it is an accurate reflection of a
truly equal distribution of disease between the two groups cannot
be distinguished in the current analysis.
It is also interesting that average size of the aneurysms treated
by standard open repair was significantly larger (6.0 cm) than the
size of aneurysms treated using EVAR (5.4 cm). It is possible that
the authors have different thresholds for performing aneurysm
repair according to the technique that is going to be used. For
patients in whom open repair is being considered, the threshold for
repair with respect to maximum aortic diameter may be higher.
Alternatively, larger aneurysms may not have anatomy suitable for
endovascular repair and consequently open repair is necessary.
Ultimately, the equivalent survival curves between the open
and endovascular repair groups suggest that patients can undergo
EVAR and thereby reduce the perioperative blood loss, hospital
length of stay, and recovery time, and still maintain longer-term
survival that is equal to patients treated by open repair. This
appears to be of particular relevance for octogenarians, in whom
the increase in perioperative mortality for open repair appears to be
most significant.
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